Navigation Links
Dragon Pharma announces 2007 full year financial results
Date:3/31/2008

margin has risen to -9.4% in 2007 compared to -12.8% in 2006.

The total operating expenses were $10.9 million in 2007 as compared to $7.7 million in 2006. The increase reflects an increase of the non-cash stock-based compensation expense and consulting fees related to Sarbanes-Oxley compliance and increased selling expenses due to an increase in sales in both the Chemical and Pharma Divisions.

As a result of the strong sales growth as well as the improved margins for both divisions, the Company realized an after-tax income from continuing operations of $4.9 million for 2007 as compared to an after-tax loss from continuing operation of $0.9 million for the year of 2006. The Company also recognized an after-tax loss from discontinued operations of $2.40 million, which was mainly due to the impact of a non-cash write-off of $3.11 million of intangible assets and goodwill with the sales of the Biotech Division. The net income was $2.50 million or $0.04 per share, which was the net of $4.9 million or $0.08 per share net income from continuing operations and $2.40 million or $0.04 per share net loss from discontinued operations.

"2007 has been an extremely positive year for Dragon Pharma," said Dragon's Chairman and CEO Mr. Yanlin Han. "The Company's solid year-over-year growth demonstrates our effectiveness and capabilities in executing our core business strategy. To achieve our goal to become a leading vertically integrated antibiotic drugs manufacturer, we will continuously broaden our product portfolio, expand market share, lower production cost by incorporating innovative technology, improve manufacturing process and efficiencies, strengthen our management team and enhance R&D capability. In early 2008, the Company has successfully launched two new products ceflazidime and cefalexin. With the expansion of our product portfolio alongside increased annual production capacity for our core products 7-ACA and Clavulanic Acid, we are confident in our a
'/>"/>

SOURCE Dragon Pharmaceutical Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related biology technology :

1. Dragon retains leading investor relations firm
2. Dragon announces new product launch; increase in annual production output capacity
3. Dragon Announces R&D Achievement in Biotech Manufacturing Process
4. Strong Demand Pushes up Both Prices and Sales Volumes for Dragons Main Products
5. Dragon Pharmaceutical Reports Growth in Sales and Profits during Second Quarter of 2007
6. Transgenomic Opens Pharmacogenomics Laboratory in China
7. PharmAthene Reports Year-End 2007 Financial Results
8. Alseres Pharmaceuticals, Inc. Reports 2007 Financial Results and Provides Company Highlights
9. China Pharma Holdings, Inc. Announces Record 2007 Year End Results
10. Huifeng Bio-Pharmaceutical (HFGB) Announces 2007 Full Year Results
11. Eisai is Granted Favorable Preliminary Injunction Ruling in Aricept(R) Patent Infringement Lawsuit Against Teva Pharmaceuticals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2014)... VEGAS , July 23, 2014  GrowBLOX Sciences, Inc. ... today that it is filing for two medical marijuana dispensary ... locations are in addition to the Clark County, ... a special use permit, as previously announced.  GrowBLOX ... to be submitting two new applications for dispensaries in the ...
(Date:7/23/2014)... 23, 2014 a2z Inc. announces that ... App, AACC Pathfinder, in its 2014 Annual Meeting ... meeting is planned for July 29-31, 2014 in Chicago, ... be to connect with global leaders in clinical chemistry, ... other areas of breaking science in laboratory medicine. , ...
(Date:7/22/2014)... D.C., June 22, 2014 Even within a phylum so ... is distinguished among other arthropods for its cruelty -- at ... Central America, the fly is a most predatory sort of ... cricket, deposits a smear of larvae, and leaves its wicked ... out. , None of this would be possible without ...
(Date:7/22/2014)... July 22, 2014 Nuclear reactors are ... produced by controlled fission chain reaction in nuclear reactors ... is used to drive a power- generating turbine. Currently ... the world’s total electricity production. Nuclear reactor market is ... construction, planned and proposed nuclear reactor projects. , Early ...
Breaking Biology Technology:GrowBLOX Sciences, Inc. Files for Two Additional Medical Marijuana Dispensaries in Las Vegas 2GrowBLOX Sciences, Inc. Files for Two Additional Medical Marijuana Dispensaries in Las Vegas 3AACC Enhances Attendee Experience at Its 2014 Annual Meeting & Clinical Lab Expo with a2z-Powered ChirpE Photo Booth and Mobile App 2AACC Enhances Attendee Experience at Its 2014 Annual Meeting & Clinical Lab Expo with a2z-Powered ChirpE Photo Booth and Mobile App 3Fly-inspired sound detector 2Fly-inspired sound detector 3Fly-inspired sound detector 4Nuclear Energy Market: Global Industry Analysis, Size, Share, Analysis, Growth and Forecast 2013 - 2019 2Nuclear Energy Market: Global Industry Analysis, Size, Share, Analysis, Growth and Forecast 2013 - 2019 3
... , , , ... VOLC ), a leader in the development, manufacturing and sales of ... disease, announced today its participation in the 2009 Transcatheter Cardiovascular Therapeutics ... for TCT includes a first look at new study data, live ...
... ROCKVILLE, Md., Sept. 21 Neuralstem, Inc. (NYSE Amex: ... (FDA) has approved its Investigational New Drug (IND) application to commence a ... disease) with its spinal cord stem cells. , , ... Neuralstem is the first company to commence a stem cell ...
... , NES-ZIONA, Israel, Sept. 21 PROLOR Biotech, ... the initiation of a Phase I clinical trial of its ... hGH-CTP is being developed to provide growth hormone ... multiple injections per week that are currently required with a ...
Cached Biology Technology:Volcano Corporation Announces Schedule of Events for the 2009 Transcatheter Cardiovascular Therapeutics (TCT) Conference 2Volcano Corporation Announces Schedule of Events for the 2009 Transcatheter Cardiovascular Therapeutics (TCT) Conference 3Volcano Corporation Announces Schedule of Events for the 2009 Transcatheter Cardiovascular Therapeutics (TCT) Conference 4Volcano Corporation Announces Schedule of Events for the 2009 Transcatheter Cardiovascular Therapeutics (TCT) Conference 5Volcano Corporation Announces Schedule of Events for the 2009 Transcatheter Cardiovascular Therapeutics (TCT) Conference 6Neuralstem Receives FDA Approval to Commence First ALS Stem Cell Trial 2Neuralstem Receives FDA Approval to Commence First ALS Stem Cell Trial 3Neuralstem Receives FDA Approval to Commence First ALS Stem Cell Trial 4PROLOR Biotech Announces Initiation of Phase I Clinical Trial for its Long-Acting Growth Hormone 2PROLOR Biotech Announces Initiation of Phase I Clinical Trial for its Long-Acting Growth Hormone 3PROLOR Biotech Announces Initiation of Phase I Clinical Trial for its Long-Acting Growth Hormone 4
(Date:7/23/2014)... starfish, and corals have in common? Aside from ... that use calcium from their environment to create ... protection. , The July issue of The ... Laboratory, addresses the challenges faced by these species ... carbon dioxide rises, the world,s oceans are becoming ...
(Date:7/23/2014)... July 23, 2014   MedNet Solutions , ... clinical study management systems, is pleased to announce ... life sciences industry executive with over 25 years ... (COO).  Clareece will be responsible for MedNet,s day-to-day ... efficiency and quality product/service delivery.  ...
(Date:7/23/2014)... news release is available in German . ... varying sensory modalities for orientation, some of which might ... example take the polarization pattern produced by sunlight in ... from the Max Planck Institute for Ornithology in Seewiesen, ... from Israel that a night active mammal, the greater ...
Breaking Biology News(10 mins):Calcification in changing oceans explored in special issue of The Biological Bulletin 2MedNet Appoints Clareece West As Chief Operating Officer 2Bats use the evening sky's polarization pattern for orientation 2
... help to raise the offspring of other group members are ... for more distant kin, a new study has found., The ... Australia, the chestnut-crowned babbler, also found that these birds work ... the young of less-related group members., The findings, published in ...
... Elser today received the G. Evelyn Hutchinson Award, the ... the July 2012 Association for the Sciences of Limnology ... Lake Biwa, Otsu, Shiga, Japan. The Hutchinson Award is ... 10 years of excellence in limnology (the study of ...
... CORVALLIS, Ore. Scientists have discovered two viruses that appear ... are important for coral growth and health, and they say ... of coral ecosystems around the world. These viruses, ... have been shown for the first time to clearly be ...
Cached Biology News:Helping family is key for social birds 2ASU ecologist receives prestigious global award for water research 2ASU ecologist receives prestigious global award for water research 3Viruses linked to algae that control coral health 2